1-3 of 3
Kristy Drafahl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development and Validation of a Highly Sensitive e1a2 (p190) BCR-ABL Test to Determine Complete Molecular Response (Minimal Residual Disease Negative) As a Primary Endpoint for Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Kristy Drafahl, David C Smith, Cristen Graham, Christine Glynn, Cindy Spittle, Scott Verrow, Victor M. Rivera, PhD, Shouryadeep Srivastava, MBBS, PhD, Kevin Hawkins, Chad Galderisi, DO
Journal: Blood
Blood (2018) 132 (Supplement 1): 1558.
https://doi.org/10.1182/blood-2018-99-113172
Published: 2018
Journal Articles

Phasing Analysis Of TKI Resistance Mutations In The BCR-ABL1 Kinase Domain and Neighboring Domains Using Next-Generation Sequencing

Jin Li, Zhenyu Yan, Agus Darwanto, Peng Fang, Weihua Liu, Kristy Drafahl, Julie Toplin, Cindy Spittle, Chad Galderisi
Journal: Blood
Blood (2013) 122 (21): 3817.
https://doi.org/10.1182/blood.V122.21.3817.3817
Published: 2013
Journal Articles

Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid Leukemia

Julie Toplin, Kristy Drafahl, Jonathan Eibl, Clark Fjeld, Thomas Yager, Staci McAdams, Kevin Hawkins, Chad Galderisi
Journal: Blood
Blood (2013) 122 (21): 2617.
https://doi.org/10.1182/blood.V122.21.2617.2617
Published: 2013